FDA Guides Cancer Trial Survival Stats: Smarter Studies Ahead
Published Date: 8/19/2025
Notice
Summary
The FDA just dropped a draft guide to help drug makers figure out the best ways to measure how long cancer patients live during clinical trials. This guide mainly focuses on smart ways to analyze survival when it’s not the main goal of the study. If you’re in the cancer drug world, this could change how you design trials and report results—so keep an eye out and get ready to adapt!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in